e-learning
resources
Monograph
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ß
2
-adrenoceptor modulation in COPD and its potential impact on cardiovascular comorbidities
Maria Gabriella Matera, Reynold A. Panettieri
Source:
Eur Respir Monogr 2020; 88: 229-237
Journal Issue:
Cardiovascular Complications of Respiratory Disorders
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Maria Gabriella Matera, Reynold A. Panettieri. ß
2
-adrenoceptor modulation in COPD and its potential impact on cardiovascular comorbidities. Eur Respir Monogr 2020; 88: 229-237
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019
Impact of cardiovascular comorbidities on COPD exacerbations
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
The association between COPD and cardiovascular disorders
Source: International Congress 2017 – COPD and comorbid cardiovascular diseases
Year: 2017
The impact of cardiovascular drugs in COPD
Source: Annual Congress 2011 - Knowing COPD by heart: a relationship beyond comorbidity
Year: 2011
The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
The impact of airway infection on cardiovascular risk during COPD exacerbations
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012
Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
Does overweight/obesity influence cardiac autonomic modulation and functional performance in COPD exacerbation?
Source: International Congress 2018 – Acutely hospitalised patients: physiotherapy interventions and assessment methods
Year: 2018
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Acute exacerbation in COPD and relationship between cardiovascular risk and functional profile
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018
The impact of comorbidities related to BMI in COPD patients
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Management of patients with asthma or COPD and cardiovascular disease: risks
versus
benefits
Source: Eur Respir Monogr 2020; 88: 66-81
Year: 2020
The effect of comorbidities on long-term survival in COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Is there a strong relationship between COPD and cardiovascular diseases?
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 453s
Year: 2007
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept